[
1. Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, Ouellet JF, et al. Consensus recommendations for the diagnosis and management of welldifferentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol 2010; 17: 49-64.10.3747/co.v17i3.484
]Search in Google Scholar
[
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-59.10.1002/cncr.11105
]Search in Google Scholar
[
3. Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G, Chan AK. Gastrointestinal carcinoids: the evolution of diagnostic strategies. J Clin Gastroenterol 2006; 40: 572-82.10.1097/00004836-200608000-00003
]Search in Google Scholar
[
4. Bornschein J, Kidd M, Malfertheiner P, Modlin IM. Gastrointestinal neuroendocrine tumors. Dtsch Med Wochenschr 2008; 133: 1505-10.10.1055/s-2008-1081099
]Search in Google Scholar
[
5. Slavec ZZ, Gaberscek S, Slavec K. The development of nuclear medicine in Slovenia and Ljubljana: half a century of nuclear medicine in Slovenia. Radiol Oncol 2012; 46: 81-8.10.2478/v10019-012-0011-5
]Search in Google Scholar
[
6. Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003; 5: 42-8.10.1016/S1536-1632(03)00038-6
]Search in Google Scholar
[
7. Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schafer M, et al.Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2007; 34: 1617-26.10.1007/s00259-007-0450-1
]Search in Google Scholar
[
8. Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007; 48: 508-18.10.2967/jnumed.106.035667
]Search in Google Scholar
[
9. Horton KM, Fishman EK. The current status of multidetector row CT and three-dimensional imaging of the small bowel. Radiol Clin North Am 2003; 41: 199-212.10.1016/S0033-8389(02)00121-5
]Search in Google Scholar
[
10. Gabriel M, Hausler F, Bale R, Moncayo R, Decristoforo C, Kovacs P, et al. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours. Eur J Nucl Med Mol Imaging 2005; 32: 1440-51.10.1007/s00259-005-1875-z16133384
]Search in Google Scholar
[
11. Ruf J, Heuck F, Schiefer J, Denecke T, Elgeti F, Pascher A, et al. Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology 2010; 91: 101-9.10.1159/00026556119996582
]Search in Google Scholar
[
12. Van Riet J, Rattat D, Verbruggen A, Mortelmans L, Mottaghy FM. Ga-68 DOTATOC PET/CT changed the therapeutic course of a patient with the sudden onset of vision problems. Clin Nucl Med 2009; 34: 27-8.10.1097/RLU.0b013e31818f458819092379
]Search in Google Scholar
[
13. Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, et al. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 2010; 252: 850-86.10.1097/SLA.0b013e3181fd37e821037441
]Search in Google Scholar
[
14. Van Hoe L, Gryspeerdt S, Marchal G, Baert AL, Mertens L. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. Am J Roentgenol 1995; 165: 1437-9.10.2214/ajr.165.6.74845817484581
]Search in Google Scholar
[
15. Stafford-Johnson DB, Francis IR, Eckhauser FE, Knol JA, Chang AE. Dualphase helical CT of nonfunctioning islet cell tumors. J Comput Assist Tomogr 1998; 22: 335-9.10.1097/00004728-199803000-000349530406
]Search in Google Scholar
[
16. Chung MJ, Choi BI, Han JK, Chung JW, Han MC, Bae SH. Functioning islet cell tumor of the pancreas. Localization with dynamic spiral CT. Acta Radiol 1997; 38: 135-8.
]Search in Google Scholar
[
17. Schreiter NF, Nogami M, Steffen I, Pape UF, Hamm B, Brenner W, et al. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours. Eur Radiol 2012; 22: 458-67.10.1007/s00330-011-2266-421904802
]Search in Google Scholar
[
18. Andersson T, Eriksson B, Hemmingsson A, Lindgren PG, Oberg K. Angiography, computed tomography, magnetic resonance imaging and ultrasonography in detection of liver metastases from endocrine gastrointestinal tumours. Acta Radiol 1987; 28: 535-9.10.1177/028418518702800507
]Search in Google Scholar
[
19. Wallace S, Ajani JA, Charnsangavej C, DuBrow R, Yang DJ, Chuang VP, et al. Carcinoid tumors: imaging procedures and interventional radiology. World J Surg 1996; 20: 147-56.10.1007/s0026899000238661810
]Search in Google Scholar
[
20. Ricke J, Hanninen EL, Amthauer H, Lemke A, Felix R. Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SH U 508A ultrasound contrast agent and color or power Doppler sonography. Invest Radiol 2000; 35: 253-9.10.1097/00004424-200004000-0000610764094
]Search in Google Scholar
[
21. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007; 48: 1741-8.10.2967/jnumed.107.04037817873136
]Search in Google Scholar
[
22. Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics 2007; 27: 145-59.10.1148/rg.27106508017235004
]Search in Google Scholar
[
23. Versari A, Camellini L, Carlinfante G, Frasoldati A, Nicoli F, Grassi E, et al. Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study. Clin Nucl Med 2010; 35: 321-8.10.1097/RLU.0b013e3181d6677c20395703
]Search in Google Scholar
[
24. Ruf J, Schiefer J, Furth C, Kosiek O, Kropf S, Heuck F, et al. 68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triplephase protocol. J Nucl Med 2011; 52: 697-704.10.2967/jnumed.110.08374121498531
]Search in Google Scholar
[
25. Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga- DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging 2010; 37: 67-77. 10.1007/s00259-009-1205-y19618183
]Search in Google Scholar
